As a chief commercial officer, David is expected to oversee the commercial strategy for Vave Health, including investment and operations, with a specific focus on sales, customer success, marketing, and business development.
Fremont, CA: Vave Health, maker of innovative wireless ultrasound technology, has declared two additions to its executive team and also advisory board to support the company's accelerated growth in the medical imaging market. David Garner, a long-time veteran of point-of-care ultrasound and previous vice president at Butterfly Network, brings over 22 years of experience to Vave Health, and Terri Bresenham, founder of TruNorth Health Advisors as well as a recognized global healthcare expert, joins as a member of the company's advisory board.
"Vave is at a critical stage of growth, having received FDA clearance in 2019 and spending much of last year optimizing our product for full-volume scale. We're poised for a year of explosive growth and need the best and brightest minds to help us accelerate in the market and amplify our message," stated Amin Nikoozadeh, founder and CEO of Vave Health. "David brings a strong track record of commercial success and a deep understanding of disruptive technologies in point-of-care imaging, making him the perfect addition to our growing team."
As a chief commercial officer, David is expected to oversee the commercial strategy for Vave Health, including investment and operations, with a specific focus on sales, customer success, marketing, and business development. When asked about his new role, David stated, "Recent years have witnessed a sea change in medical imaging, specifically in low cost, artificial intelligence-driven, portable ultrasound, making imaging accessible to more health care providers, and therefore, more patients. I couldn't be more excited about joining Vave Health to achieve the company's vision of making imaging accessible to all."
"As Vave Health continues to scale, we must have a strong, trusted group of advisors helping us navigate the market," stated Nikoozadeh. "Having led both GE's ultrasound and molecular imaging businesses, I am confident that Terri's knowledge and guidance will be instrumental in continuing our development, especially as we look to expand into global markets."
